Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 456906 in overweight/obesity without diabetes
CTR20210717Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of survodutide in obesity, Overweight, sponsored by Boehringer Ingelheim. Started Apr 2021; status: completed.
02
Drugs
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on CTR20210717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210717.